Capital Offload-Shock

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorOttawa Heart Institute Research Corporation

About this trial

CAPITAL OFFLOAD-SHOCK will aim to answer if early use of renal replacement therapy, like dialysis, in patients with reduced body fluids causing the heart to be unable to pump enough blood through the body reduces in-hospital death when compared to the current standard of care. The current standard of care is to wait until renal replacement therapy is clinically necessary.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adult patients >/= 18 years of age admitted to an intensive care unit

Diagnosed clinically with Society for Cardiovascular Angiography and Interventions (SCAI) Class C or D cardiogenic shock

Clinical or hemodynamic evidence of volume overload

Disqualifiers

Patients whose care plan, as determined by the treating clinical team, will not include renal replacement therapy

Decision has already been made by the treating clinical team to initiate renal replacement therapy

Hyperkalemia with serum potassium >/= 6mmol/L at the time of screening

Severe metabolic acidosis with serum bicarbonate </= 12 mmol/L at the time of screening

Trial design

Design model

Parallel

Treatments tested in this trial

  • Immediate renal replacement therapy

    Drug

    Renal replacement therapy started within 6 hours of randomization

Treatment groups

456 Participants
are divided into 2 treatment groups
Group A: Immediate Renal Replacement TherapyExperimental treatment 1 intervention
Group B: Standard Medical TreatmentNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

All cause mortality

Occurrences of death from any cause

Time frame
Baseline to 90 days
2

Increased serum lactate

Serum lactate greater than 3.5 mmol/L between 6 and 24 hours after randomization

Time frame
Randomization to 24 hours post randomization.
3

Mechanical circulatory support

New need for, or replacement of, a mechanical circulatory support device.

Time frame
Baseline to Hospital Discharge - expected up to 90 days
4

Resuscitated cardiac arrest

Occurrences of resuscitated cardiac arrest

Time frame
Baseline to Hospital Discharge - expected up to 90 days

Secondary outcomes

1

Continued renal replacement therapy

Renal replacement therapy dependence for participants at discharge from index hospitalization

Time frame
Baseline to Hospital Discharge - expected up to 90 days
2

Length of hospital stay

Number of days spent in hospital

Time frame
Baseline to Hospital Discharge - expected up to 90 days
3

Length of intensive care unit stay

The number of days spent in the intensive care unit during index hospitalization

Time frame
Baseline to Hospital Discharge - expected up to 90 days
4

Major bleeding events

Bleeding events defined as the Bleeding Academic Research Consortium (BARC) type 3 or higher)

Time frame
Baseline to Hospital Discharge - expected up to 90 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: